Key Highlights

● Net sales rose 33% to roughly $1.91 billion.

● GOJO added about 15 points and Organic Sales rose 18%.

● Gross Margin fell to 40.4% as costs outran savings.

● Fabian Garcia becomes chief executive on the fifth of January, succeeding Linda Rendle.

Clorox (NYSE:CLX) reported first-quarter results for the new fiscal year on Monday after the close of trading, and the headline numbers looked strong at first glance. Net sales climbed about 33% to roughly $1.91 billion, Diluted Earnings per Share more than doubled to $1.39, and adjusted earnings per share rose to $1.55. Most of the jump, however, came from two items that management had flagged in advance: the newly acquired GOJO Business and a comparison against a year-earlier quarter depressed by an inventory drawdown tied to a systems changeover.

The details beneath the surface were more mixed. Gross margin fell by 130 basis points to 40.4% as commodity, Manufacturing and logistics costs rose faster than savings, and the company said full-year adjusted earnings per share should now come in nearer the low end of its unchanged $5.70 to $6 range. The report arrived only days after Clorox named a new chief executive, adding a management change to a year already full of integration work.

For readers following Consumer Stocks, the quarter is a useful case study in how a household and health products maker can post a very large percentage gain while its underlying cost picture tightens.

What did Clorox actually report for the quarter?

The company said net sales for the three months ended in September were about $1.91 billion, up 33%. Net earnings attributable to Clorox were $170 million, against $80 million a year earlier. Earnings before taxes were $207 million, nearly double the $107 million of the prior-year period, and adjusted operating earnings reached $284 million versus $160 million.

On a per-share basis, diluted earnings were $1.39, up from $0.65. Adjusted earnings per share, which strip out Acquisition costs and other items, were $1.55 compared with $0.85. The release stated that lapping the earlier inventory drawdown alone contributed about $0.90 to the year-over-year change, which means that most of the improvement was a rebound to a normal base rather than fresh momentum.

How much of the sales jump came from GOJO and the easy comparison?

GOJO, the maker of Purell hand hygiene products that Clorox completed acquiring on the first of April, added about 15 percentage points to net sales growth. Organic sales, which exclude acquisitions and currency effects, rose 18%. The release attributed most of that organic gain to the fact that the year-earlier quarter was weighed down by a large drawdown of retailer inventory during an enterprise software transition.

In other words, the quarter contained a one-time rebound that will not repeat. The company's own full-year guidance reflects this: organic growth for the year is expected in a range of three and a half to 4.5%, and more than three and a half points of that comes from lapping the drawdown. Stripping out that effect leaves a modest underlying growth rate for the remainder of the fiscal year.

Readers comparing the two measures should note that the reported growth rate of 33% is the sum of three pieces: the acquisition, the lapped drawdown and a small amount of ordinary growth. Only the last piece speaks to how many bottles, wipes and bags of charcoal shoppers are choosing week to week, and the release does not isolate it. Management guidance for the year implies that the ordinary piece is modest.

Why did gross margin fall despite the Volume rebound?

Gross margin was 40.4%, down from 41.7% a year ago. The company cited higher Commodity costs and higher manufacturing and logistics costs, partly offset by the benefit of higher volume and ongoing cost savings. The accounting step-up of GOJO inventory, which temporarily raises the cost of goods as acquired stock is moved through, took roughly 50 basis points off the figure.

Margin pressure matters because the volume recovery would normally lift margin through fixed-cost absorption. That it did not shows how large the cost increases were. A call-summary headline from one financial site pointed to about $240 million of cost Inflation in the fiscal year, a figure drawn from management commentary rather than the release tables, and an earlier preview headline had used a similar order of magnitude.

Gross margin also feeds the guidance. The updated full-year figure of about 41.5% sits above the first-quarter reading, which implies the company expects costs to ease or savings to build as the year proceeds. Whether that happens depends largely on commodity markets that management does not control, and the phrase about the low end of the earnings range shows that the company sees the balance of influences as tilted against it for now.

How did the four business segments perform?

Health and Wellness was the largest and fastest-growing unit, with net sales of $918 million, up 62%, and organic growth of 23%. Its segment adjusted Earnings before interest and taxes rose 69% to $209 million. Household, which includes cleaning and laundry brands, grew 17% to $423 million, with segment earnings of $30 million, up 11%.

Lifestyle, home to food and natural personal care brands, posted sales of $283 million, up 16%, and segment earnings of $60 million, up 58%. International sales were $281 million, up 11%, with organic growth of 9% and segment earnings of $31 million, up 63%. Every segment grew, though the starting point was a weak year-earlier base.

The mix matters for the margin story. Health and Wellness now carries GOJO and is the biggest contributor to sales growth, while Household, the lowest-earning segment relative to its sales, grew more slowly. Segment earnings margins differ widely, from roughly 7% in Household to just over 21% in Lifestyle, so the shift in weight among segments affects consolidated margin as well as the headline growth rate.

What changed in the full-year guidance for Clorox?

The company kept its net sales growth range at 13 to 14%, including about nine and a half points from GOJO. Adjusted earnings per share remain at $5.70 to $6, which is a gain of 3 to 8% from last year's $5.53. What changed is the language: management now expects to land nearer the low end because of rising input costs.

Several line items were updated. Gross margin is now projected at about 41.5%, including roughly 20 basis points of drag from the inventory step-up. Administrative and marketing-related overhead is seen at about 15.5% of sales, including about 40 basis points of GOJO transaction costs. Advertising and sales promotion remains near 10% of sales, or about 12% for retail businesses, and the tax rate is expected near 23%.

Taken together, the updated ranges describe a year in which sales growth is large, helped by the acquisition and the lapping benefit, while earnings growth is small. The gap between the two is explained by the cost increases, acquisition expenses, higher interest from Debt used for the transaction and the higher tax rate. Management did not change the sales growth range, so the downward pressure shows up only in the earnings line.

What did the acquisition cost the company in the period?

GOJO Transaction Costs in the quarter were about $26 million before tax, or $20 million after tax. For the full year the company expects about $46 million before tax, or $35 million after tax. These expenses explain much of the gap between diluted earnings per share guidance of $5.41 to $5.71 and the adjusted range, which includes roughly $0.29 of deal-related charges.

The acquisition also changed the balance sheet. At the end of September, Clorox reported cash of $184 million, notes and loans payable of about $1.175 billion and long-term debt of about $3.982 billion. Operating Cash Flow for the quarter was $143 million, up from $93 million a year earlier.

Who is Fabian Garcia and why was he named chief executive?

On the 20-ninth of October the board appointed Fabian Garcia, currently president of Unilever Personal Care, as chief executive effective the fifth of January. He joined Unilever in 2020 after serving as chief executive of Revlon, as chief operating officer for global innovation and growth at Colgate-Palmolive and in a series of global roles at Procter and Gamble. He also sits on the board of Wells Fargo and previously served on the boards of Kimberly-Clark and Arrow Electronics.

Garcia succeeds Linda Rendle, who said in May that she would step down for health reasons. Rendle remains chair and chief executive until the handover, then leaves the board and acts as an adviser through early April. Matthew Shattock, the lead independent director, becomes independent chair. The board said it was confident Garcia could build on Rendle's foundation and strengthen execution, while Garcia described the Brand portfolio as exceptional.

The appointment draws on an executive with experience across household, beauty and personal care categories, which overlap with several Clorox brands. The company statements did not describe his plans, and the board's wording focused on execution and sustainable value creation, so details on priorities will probably emerge after he starts.

How does the timing of the chief executive change affect the quarter?

Rendle and chief financial officer Luc Bellet led the earnings webcast, which had been scheduled in October well before the chief executive news. That meant the guidance language on Monday came from the outgoing team, while the incoming chief executive will own delivery for most of the fiscal year, including the second half when the lapping benefit fades.

The handover also coincides with integration work on GOJO and with continued cost pressure. A transition of this kind is a normal feature of corporate life, but it adds a layer of attention to any report from the company until the new leader sets out priorities. Clorox gave no detail about changes to strategy, and the release is silent on whether the guidance was set with the incoming chief executive's input.

What does the consumer backdrop look like around these results?

Household and health product makers have been dealing with a mix of higher commodity costs, retailer inventory adjustments and consumers who compare prices more closely. Clorox's results show that pattern in miniature: volume recovered because of an easy comparison, while the cost structure absorbed more commodity and logistics expense than it could offset through savings programs.

The company's brand list, which includes Clorox, Glad, Pine-Sol, Kingsford, Brita, Burt's Bees, Fresh Step, Hidden Valley, Liquid-Plumr and Purell, spans cleaning, charcoal, water filtration, pet litter, dressings and personal care. That range means the company has exposure to resin, chemicals, soybean oil, fuel and packaging at once, so cost shifts rarely arrive in only one place.

Retail customers also matter. Large chains manage inventory tightly and adjust orders when their own sales slow, which is exactly what produced the year-earlier distortion. With that comparison now behind the company for the first quarter, order patterns should look closer to consumption patterns, though promotional timing can still cause quarter-to-quarter swings.

How did the previous fiscal year set the stage?

Last fiscal year's diluted earnings per share were $4.81 and adjusted earnings per share were $5.53. The inventory drawdown reduced that year's earnings by about $0.90, according to the release, which is the same amount the lapping effect adds back this year. Put differently, a clean comparison would have shown adjusted earnings per share of roughly $6.40 last year.

That arithmetic helps explain why full-year adjusted guidance of $5.70 to $6 represents such a small gain. The base is not as low as the reported figure indicates, and cost inflation plus acquisition accounting now absorb a good part of the recovery.

The year-earlier quarter also illustrates how dependent a consumer products maker is on retailer ordering. When the company changed its internal ordering and shipping systems, retailers drew down stock on shelves and in warehouses, and Clorox shipped less than shoppers took home. The reverse happened this quarter as shipments normalized, which is why reported growth looks far stronger than consumption data would.

Which items should readers watch next?

The next report will be the first covering a period after the new chief executive takes office, although the handover occurs only weeks into that quarter. Items to follow include the pace of input cost inflation, whether pricing actions are used, progress integrating GOJO, and the organic growth rate once the easy comparison fades in the second half.

The company said it expects advertising and sales promotion near 10% of sales, so Marketing spending is not the lever being pulled to defend earnings. Cost savings and mix are, which makes the gross margin line the single most closely watched number in the coming reports.

The company's debt load is another item. Notes and loans payable plus long-term debt total more than $5 billion, against cash of under $200 million, so interest expense and the pace of debt reduction will feature in coming reports. Management has not given a specific repayment schedule in the release summarized here.

Where does Clorox sit in the market?

Clorox, headquartered in Oakland, California since 1913, is a member of the S&P 500 and is listed on the New York Stock Exchange. It is one of the larger independent household brand owners in North America, competing with much bigger multinationals in several categories with leading shares in bleach, charcoal, cat litter and water filtration.

Share price moves are not part of the company release and are not examined here. The sections above focus on the reported figures and the guidance, which are verifiable from the primary document.